A new study finds that an easily measurable brain wave shift of phase may be a universal marker of unconsciousness under general anesthesia.

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Research into chemical discovery, testing optimization and analysis can be a labor-intensive and time-consuming process. With ...

The US federal agency responsible for regulating medicines wants to speed up the evaluation process using the cderGPT ...

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following ...

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

In the pivotal, Phase III NUC-5 trial, (NCT03872921), NCA showed statistical superiority over placebo in achieving the ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The phase 2 clinical trial data evaluating the efficacy, safety, and dosing intervals of high-dose ... The study lasted 52 weeks. “Current drug development focuses on multi-target strategies and ...